UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care

BMC pediatrics, 2012-06, Vol.12 (1), p.78-78, Article 78

2012

Volltextzugriff (PDF)

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

Drug safety, 2009-01, Vol.32 (6), p.499-507

2009

Volltextzugriff (PDF)

The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England

Obesity (Silver Spring, Md.), 2007-11, Vol.15 (11), p.2712-2722

2007

Volltextzugriff (PDF)

A Postmarketing Surveillance Study of Gabapentin as Add‐on Therapy for 3,100 Patients in England

Epilepsia (Copenhagen), 2002-09, Vol.43 (9), p.983-992

2002

Volltextzugriff (PDF)

Trends and patterns of hormonal contraceptive prescribing for adolescents in primary care in the U.K

The journal of family planning and reproductive health care, 2015-07, Vol.41 (3), p.216

2015

Volltextzugriff (PDF)

Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence

BMC psychiatry, 2012-12, Vol.12 (1), p.219-219, Article 219

2012

Volltextzugriff (PDF)

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

BMJ (Online), 2001-03, Vol.322 (7287), p.651-652

International edition, 2001

Volltextzugriff (PDF)

Prescription-event monitoring and reporting of adverse drug reactions

The Lancet (British edition), 2001-12, Vol.358 (9296), p.1872-1873

2001

Volltextzugriff (PDF)

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

European journal of clinical pharmacology, 2003-12, Vol.59 (10), p.767-773

2003

Volltextzugriff (PDF)

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

Journal of psychopharmacology (Oxford), 2005-09, Vol.19 (5), p.473-482

2005

Volltextzugriff (PDF)

The safety profile of tadalafil as prescribed in general practice in England: results from a prescription‐event monitoring study involving 16 129 patients

BJU international, 2009-02, Vol.103 (4), p.506-514

2009

Volltextzugriff (PDF)

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

BMJ (Online), 1998-07, Vol.317 (7151), p.119

International edition, 1998

Volltextzugriff (PDF)

Pharmacovigilance study of alendronate in England

Osteoporosis international, 2003-07, Vol.14 (6), p.507-514

2003

Volltextzugriff (PDF)

Safety profile of rosuvastatin : Results of a prescription-event monitoring study of 11 680 patients

Drug safety, 2007, Vol.30 (2), p.157-170

2007

Volltextzugriff (PDF)

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin

British journal of clinical pharmacology, 2005-07, Vol.60 (1), p.98-102

2005

Volltextzugriff (PDF)

Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England: Results from a Modified Prescription-Event Monitoring Study

Drug safety, 2009, Vol.32 (1), p.43-54

2009

Volltextzugriff (PDF)

The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England

Journal of psychopharmacology (Oxford), 2007-06, Vol.21 (4), p.392-399

2007

Volltextzugriff (PDF)

Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England

Drug safety, 2008-01, Vol.31 (10), p.839-850

2008

Volltextzugriff (PDF)

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

Journal of psychopharmacology (Oxford), 2001-03, Vol.15 (2), p.120-126

2001

Volltextzugriff (PDF)

Safety Profile of Esomeprazole: Results of a Prescription-Event Monitoring Study of 11 595 Patients in England

Drug safety, 2008, Vol.31 (4), p.313-323

2008

Volltextzugriff (PDF)

Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

BJU international, 2006-07, Vol.98 (1), p.125-131

2006

Volltextzugriff (PDF)

A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoring

Pharmacoepidemiology and drug safety, 2007-09, Vol.16 (9), p.969

2007

Volltextzugriff (PDF)

An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease

BJU international, 2007-02, Vol.99 (2), p.387-393

2007

Volltextzugriff (PDF)

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

Journal of psychopharmacology (Oxford), 2001-12, Vol.15 (4), p.265-271

2001

Volltextzugriff (PDF)

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: Postmarketing surveillance data in England

Drug safety, 2003-01, Vol.26 (8), p.589-597

2003

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(118)
Reviews
(1)

Sprache

Englisch
(119)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(72)
Science & Technology
(72)
Humans
(71)
Male
(62)
Female
(57)
Biological And Medical Sciences
(45)
Medical Sciences
(45)
Adult
(43)
Pharmacology & Pharmacy
(43)
Middle Aged
(41)
Pharmacology. Drug Treatments
(41)
Cohort Studies
(38)
Public, Environmental & Occupational Health
(31)
Aged
(30)
Drug Toxicity And Drugs Side Effects Treatment
(27)
England
(23)
Adolescent
(22)
Toxicology
(22)
Child
(20)
Prescription-Event Monitoring
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England

A Postmarketing Surveillance Study of Gabapentin as Add‐on Therapy for 3,100 Patients in England

Trends and patterns of hormonal contraceptive prescribing for adolescents in primary care in the U.K

Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

Prescription-event monitoring and reporting of adverse drug reactions

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

The safety profile of tadalafil as prescribed in general practice in England: results from a prescription‐event monitoring study involving 16 129 patients

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

Pharmacovigilance study of alendronate in England

Safety profile of rosuvastatin : Results of a prescription-event monitoring study of 11 680 patients

Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin

Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England: Results from a Modified Prescription-Event Monitoring Study

The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England

Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

Safety Profile of Esomeprazole: Results of a Prescription-Event Monitoring Study of 11 595 Patients in England

Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler into general practice in England: an example of pharmacovigilance planning and risk monitoring

An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: Postmarketing surveillance data in England

Suchergebnisse filtern